Editorial: Immune-Related Adverse Events for Patients With Lung Cancer

• Ruoning Yang,
• Ruoning Yang,
• Haiyang Wang,
• Xiaomeng Yin,
• Benjamin Frey,
• Udo S. Gaipl,
• Hubing Shi,
• Xuelei Ma

Affiliations

Ruoning Yang

Department of Biotherapy, State Key Laboratory of Biotherapy, Cancer Center, West China Hospital, Sichuan University, Chengdu, China

Ruoning Yang

Department of Breast Surgery, Clinical Research Center for Breast, West China Hospital, Sichuan University, Chengdu, China

Haiyang Wang

Department of Otolaryngology Head and Neck Surgery, West China Hospital, Sichuan University, Chengdu, China

Xiaomeng Yin

Department of Biotherapy, State Key Laboratory of Biotherapy, Cancer Center, West China Hospital, Sichuan University, Chengdu, China

Benjamin Frey

Translational Radiobiology, Universitätsklinikum Erlangen, Erlangen, Germany

Udo S. Gaipl

Translational Radiobiology, Universitätsklinikum Erlangen, Erlangen, Germany

Hubing Shi

Department of Biotherapy, State Key Laboratory of Biotherapy, Cancer Center, West China Hospital, Sichuan University, Chengdu, China

Xuelei Ma

Department of Biotherapy, State Key Laboratory of Biotherapy, Cancer Center, West China Hospital, Sichuan University, Chengdu, China